Freedman NM - Search Results

1

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

Ortu G, Ben-David I, Rozen Y, Freedman NM, Chisin R, Levitzki A, Mishani E. Ortu G, et al. Among authors: freedman nm. Int J Cancer. 2002 Oct 1;101(4):360-70. doi: 10.1002/ijc.10619. Int J Cancer. 2002. PMID: 12209961

2

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

Bonasera TA, Ortu G, Rozen Y, Krais R, Freedman NM, Chisin R, Gazit A, Levitzki A, Mishani E. Bonasera TA, et al. Among authors: freedman nm. Nucl Med Biol. 2001 May;28(4):359-74. doi: 10.1016/s0969-8051(01)00200-1. Nucl Med Biol. 2001. PMID: 11395308

3

11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.

Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON. Orevi M, et al. Clin Nucl Med. 2012 Apr;37(4):e67-72. doi: 10.1097/RLU.0b013e31824786e7. Clin Nucl Med. 2012. PMID: 22391726

4

In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.

Freedman NM, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, Ehrlich D, Chisin R. Freedman NM, et al. J Nucl Med. 2005 Oct;46(10):1618-24. J Nucl Med. 2005. PMID: 16204711 Free article.

5

Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Ilovich O, Billauer H, Dotan S, Freedman NM, Bocher M, Mishani E. Ilovich O, et al. Among authors: freedman nm. Mol Imaging Biol. 2011 Feb;13(1):128-39. doi: 10.1007/s11307-010-0336-7. Mol Imaging Biol. 2011. PMID: 20480244

6

Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.

Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, Shapiro A, Katz R, Libson E, Chisin R. Gofrit ON, et al. J Urol. 2006 Sep;176(3):940-4; discussion 944. doi: 10.1016/j.juro.2006.04.018. J Urol. 2006. PMID: 16890661

7

Structure--activity relationship and preclinical evaluation of carbon-11-labeled ammonium salts as PET--myocardial perfusion imaging agents.

Ilovich O, Abourbeh G, Bocher M, Freedman N, Billauer H, Dotan S, Danenberg HD, Mishani E. Ilovich O, et al. Mol Imaging Biol. 2012 Oct;14(5):625-36. doi: 10.1007/s11307-011-0539-6. Mol Imaging Biol. 2012. PMID: 22290562

8

Gating, enhanced gating, and beyond: information utilization strategies for motion management, applied to preclinical PET.

Kesner AL, Abourbeh G, Mishani E, Chisin R, Tshori S, Freedman N. Kesner AL, et al. EJNMMI Res. 2013 Apr 24;3(1):29. doi: 10.1186/2191-219X-3-29. EJNMMI Res. 2013. PMID: 23618039 Free PMC article.

9

68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®).

Krausz Y, Freedman N, Rubinstein R, Lavie E, Orevi M, Tshori S, Salmon A, Glaser B, Chisin R, Mishani E, J Gross D. Krausz Y, et al. Mol Imaging Biol. 2011 Jun;13(3):583-593. doi: 10.1007/s11307-010-0374-1. Mol Imaging Biol. 2011. PMID: 20652423 Clinical Trial.

10

Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment.

Weinstein AM, Freedman N, Greif J, Yemini Z, Mishani E, London E, Chisin R, Bocher M. Weinstein AM, et al. Am J Addict. 2016 Sep;25(6):486-92. doi: 10.1111/ajad.12419. Epub 2016 Jul 28. Am J Addict. 2016. PMID: 27467186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters